1. Introduction {#Section1}
===============

Chemiluminescence (CL), as a widely used photon emission-based analytical technique, has developed rapidly from the late 1970s [@B1]. CL can be described as the phenomenon of emitting photons when electrons return from the excited state to the ground state during a chemical reaction. Compared with traditional detection techniques, the most remarkable advantage of CL is the high sensitivity resulted from no need of an external light source. Therefore, CL can reduce the light scattering, improve SNR and detection sensitivity, and expand the linear dynamic range. Since horseradish peroxidase (HRP) was first reported to catalyze the oxidation of luminol by H~2~O~2~, the CL signals were amplified extremely and the CL assays were also developed increasingly. In addition to luminol, many CL substrates, such as acridinium ester, peroxyoxalate, 1,2-dioxetane and their derivatives, have been found. With the development of CL systems and advanced analytical equipment with high resolution such as photomultiplier tube and charge-coupled device (CCD), CL imaging technology has become attractive in *in vitro* and *in vivo* applications [@B2], [@B3]. To get better imaging effect, CCD-based imaging devices have become more and more popular [@B4]. Slow-scan CCD detectors are suitable for steady-state CL signal with a high quantum effect [@B5]. Meanwhile, cryogenic freezing technology can reduce noise and promote SNR. Further, intensified CCD and imaging photon detectors provide high sensitivity in CL detection [@B6]. At present, the commercial development of CCD devices with high sensitivity and high resolution makes the application of CL imaging more widely. It is easy to measure photon signals in microarrays to achieve simultaneous analysis of multicomponent substances, in which the amounts of the samples are greatly reduced. Up to now, CL imaging technology has been applied to detect a wide range of analytes in the field of biochemical analysis, including nucleic acids, proteins, enzymes, small biological molecules, and even cells [@B7], [@B8].

To monitor the diverse *in vivo* processes such as tumor growth, drug delivery and pathogen shifts, practicable and high-resolution optical imaging technologies have been developed [@B9]. In particular, *in vivo* CL imaging has great significance for evaluation of cell and animal models and real-time monitoring of physiology and pathology processes [@B10]. With the continuous progress of novel CL materials and optical detection technologies, the research on CL imaging will be further expanded, and the existing limitations, such as the precision of target localization, will be broken.

In view of the weak tissue penetration and short timeliness of *in vivo* CL imaging models, some important physiological and pathological processes in living systems cannot be monitored, especially in deep tissues [@B11]. Alternatively, bioluminescence (BL) imaging has become one of the most popular noninvasive *in vivo* tools in the past decade. BL is generated via enzymatic reaction through the conversion of chemical energy into light in living organism without excitation source. In a typical BL reaction, luciferase catalyzes the oxidation of the substrate (e.g., luciferin). So far, a variety of luciferases are used in BL systems and many of them can be used to in-depth image cells and tissues [@B12]. For example, the most striking NanoLuc can offer enhanced stability which has smaller size than Firefly and *Renilla* luciferases [@B13]. Due to its good biocompatibility and persistence, BL imaging has been used to monitor gene expression, cellular and intracellular motility, protein interactions in cells, tissues and organs [@B14]. Because of the diversity of the luciferase-luciferin pairs in BL systems, BL imaging has achieved simultaneous determination of multi-components. Based on the unique properties, the penetration, specificity and persistence of*in vivo* BL systems have been greatly improved. To obtain higher sensitivity, redesigned luciferase mutants and luciferin analogs are also emerging [@B15].

As mentioned above, both CL and BL are well-established photon emission-based detection technologies, which hold the advantages in terms of no requirement of external light source and avoiding the photobleaching, background interference and autoluminescence. Thus, CL and BL have achieved high sensitivity and wide application ranges. In this review, the *in vitro* and *in vivo* applications of CL and BL imaging technologies are overviewed. Although some review articles have been previously published on CL and BL imaging, most of them focused on the *in vitro* CL imaging assays based on traditional CL systems as well as the *in vivo* BL imaging using common luciferase-luciferin pairs. However, the *in vivo* CL imaging and retooling BL systems are rarely mentioned. In this review, we first summarize the recent research advances of *in vitro* CL imaging from the perspective of the improvement of detection sensitivity. Then, the development and applications of*in vivo* CL imaging are introduced. Moreover, the *in vivo* BL imaging systems are summarized, including in situ formation of luciferase and luciferase mutants for BL imaging, in situ formation of luciferin and luciferin analogs for BL imaging, and bioluminescence resonance energy transfer (BRET) imaging. Finally, the limitations and future perspectives of CL and BL imaging technologies are provided.

2. *In vitro* CL imaging {#Section2}
========================

As a powerful optical technique, CL imaging has been versatilely applied in *in vitro* detection of a wide range of analytes, such as nucleic acids, proteins, small molecules and even cells [@B16]. Up to now, some reviews about CL imaging have been published, which were summarized on the basis of analytical formats such as microtiter plates and microarrays [@B2] or according to the analytes [@B17]. However, at present the major challenge of *in vitro* CL imaging is how to improve the detection sensitivity. Therefore, we summarize the recent research advances of *in vitro* CL imaging from three representative parts regarding to improve the sensitivity: nanoprobe-based CL imaging for signal amplification, isothermal amplification-based CL imaging assays, and integrated CL imaging devices.

2.1. Nanoprobe-based CL imaging for signal amplification {#Section2.1}
--------------------------------------------------------

To improve the detection sensitivity, novel CL probes have been explored and applied in CL imaging [@B6], [@B18]-[@B20]. For example, gold nanoparticles (AuNPs) have been widely used as labels for signal amplification [@B21]-[@B23]. Through binding HRP molecules to AuNPs with a high loading ratio [@B24], CL imaging platforms have been developed for the detection of various tumor markers [@B25]-[@B27], achieving cancer screening with high throughput, good reproducibility and high accuracy. Meanwhile, using HRP-labeled AuNPs as nanoprobes, human cancer cells were imaged and the glycan expression on cell surface was monitored (**Figure [1](#F1){ref-type="fig"}A**) [@B28]. In particular, because of the high chemical stability, enhanced catalytic activity and low cost in comparison with HRP molecules, G-quadruplex/hemin HRP-mimicking DNAzyme has been widely used in biochemical analysis [@B29], [@B30]. Ju\'s group developed a CL imaging immunoassay using multilayer hemin/G-quadruplex coated AuNPs as probes for simultaneous detection of multiple antigens with ultrahigh sensitivity [@B25].

Recently, bio-bar-code AuNP probes have proven to be able to significantly improve the detection sensitivity through efficiently avoiding cross reaction [@B31]-[@B33]. In the construction of bio-bar-code probes, AuNPs as carriers are functionalized with both bar-code DNAs and specific identification elements such as antibody and aptamer with a ratio of n:1, which thus decreases the recognition reaction from one-to-many to one-to-few and realizes signal amplification [@B34]. Through combining CL imaging array and bio-bar-code AuNPs, Bi et al. realized the ultrasensitive detection of human Burkitt\'s lymphoma cells with a LOD as low as 163 cells (**Figure [1](#F1){ref-type="fig"}B**) [@B35].

Inorganic luminescent nanomaterials with high photo-intensity were also used in CL imaging systems as novel probes. Quantum dots (QDs) are a class of semiconductor nanomaterials with adjustable emission spectra and long fluorescence life so that they are suitable for the construction of luminescent probes in CL imaging assays. In particular, nitrogen-doped graphene quantum dots (NGQDs) with excellent light stability have been used as luminescence probes for ascorbic acid detection based on the catalysis of copper ion [@B36].

In addition, polymers have also been employed as probes in CL imaging assays. Through using molecularly imprinted polymers as recognition probes, the selectivity of CL imaging has been significantly improved [@B37]-[@B39], achieving sensitive and specific detection of a variety of small organic molecules, such as 2,4-dichlorophenoxyacetic acid [@B40], trans-resveratrol [@B41], dipyridamole [@B42] and dansyl-phenylalanine [@B43]. Recently, using folic acid and HRP-bifunctionalized semiconducting polymer dots as integrated probes, a CL platform was developed for imaging of cancer cells and targeted photodynamic therapy (PDT) of tumors via chemiluminescence resonance energy transfer (CRET) (**Figure [1](#F1){ref-type="fig"}C**) [@B44].

2.2. Isothermal amplification-based CL imaging assays {#Section2.2}
-----------------------------------------------------

As a commonly used molecular biology technique for amplification, polymerase chain reaction (PCR) has been widely used in diagnosis of diseases due to its high amplification efficiency. So far, a variety of PCR-based CL imaging strategies have been developed for biomolecular analysis [@B45]-[@B49]. However, PCR often suffers from the disadvantages of complicated temperature control and nonspecific amplification. Alternatively, isothermal amplification strategies, such as tool enzyme-assisted signal amplification methods [@B50]-[@B53] and toehold-mediated strand displacement reaction [@B54], have been versatilely applied in CL imaging of nucleic acids [@B50], [@B51], [@B55], [@B56], cancer cells [@B35] and bacteria [@B52]. For example, Seidel et al. developed a flow CL imaging microarray MCR 3 based on recombinase polymerase amplification (RPA) for multiplex detection of viral and bacterial DNA (**Figure [2](#F2){ref-type="fig"}A**) [@B52]. This on-chip isothermal nucleic acid amplification test (iNAAT) was performed at a constant temperature of 39 ^o^C. After immobilizing HRP molecules on the chip via specific interaction between biotin and strepavidin, HRP catalyzed the CL reaction of luminol-H~2~O~2~ and the signals were collected by a CCD camera for CL imaging.

In addition, through combining DNA polymerase/nicking enzyme-assisted molecular machine with programmable toehold-mediated strand displacement reactions, a CL imaging array was reported for simultaneous detection of three miRNAs with high throughput (**Figure [2](#F2){ref-type="fig"}B**) [@B57]. In this assay, three kinds of hairpins were immobilized on magnetic particles. The introduction of different target miRNAs initiated the DNA machine in the presence of Klenow exo- polymerase and Nb.BbvCI nicking enzyme, resulting in the displacement of target miRNAs and the generation of a large number of single-stranded DNAs to trigger another DNA machine. After sequential addition of three displacement probes, HRP-tagged DNA strands were released from magnetic particles based on toehold-mediated strand displacement, achieving simultaneous CL imaging of three miRNAs (miR-155, miR-let-7a and miR-141) with the detection limits as low as fM level.

2.3. Integrated CL imaging devices {#Section2.3}
----------------------------------

In recent years, many miniaturized and integrated CL imaging devices, such as microfluidic cloth-based analytical devices (μCADs), have been developed for small molecule detection [@B58], [@B59]. In addition, a variety of CL imaging devices have been reported for efficient and sensitive analysis of proteins, such as microfluidic-based chips [@B60], lateral flow-based disposable cartridge [@B61], capillary isoelectric focusing immunoassay [@B63], paper-based microfluidic sensor [@B64], and 3D printing-based all-in-one immuno-device (**Figure [3](#F3){ref-type="fig"}**) [@B62]. With the continuous development of imaging equipment and techniques, scanning CL microscopy (SCLM) has been developed [@B65], [@B66]. Moreover, scanning electrochemical microscopy (SECM) was combined with luminescence technique [@B67]. For example, SECM/electrogenerated chemiluminescence (ECL) setup was established and applied for the detection of enzyme activity [@B68]. The automation of these devices dramatically shortened the operation time and improved sensitivity, which can be versatilely applied in clinical diagnosis.

3. *In vivo* CL imaging {#Section3}
=======================

To better understand the gene expression, pathogenesis and treatment of diseases in depth, intracellular and intra-tissue imaging are essential. With the development of the optical equipment, CL has been well advanced from *in vitro* imaging to *in vivo* imaging. To resolve the problem of light transmittance and tissue self-absorption during CL imaging *in vivo*, novel and biocompatible CL probes have been fabricated, such as multifunctional polymer nanoparticles (NPs) [@B69] and near-infrared (NIR) fluorescent dyes [@B70]-[@B72]. It should be noted that the NIR fluorescence generated from these fluorescent dyes is not direct CL emission but the non-radiative energy transfers from the CL substrate to fluorescent receptor which can emit at NIR region. Meanwhile, *in vivo* CRET systems have been developed to enhance the CL emission using fluorescein, QDs, AuNPs, graphene and graphene oxide (GO) as the energy acceptors. All of these meaningful improvements have led to the excellent sensitivity and high accuracy of *in vivo* CL imaging [@B73]-[@B76].

3.1. Peroxyoxalate chemiluminescence (POCL) polymer-based CL imaging {#Section3.1}
--------------------------------------------------------------------

Unlike *in vitro* detection, tissue self-absorption and low penetrability limit the application of traditional CL imaging systems in *in vivo* imaging. In view of this, novel CL imaging probes were fabricated. Using peroxyoxalate and corresponding polymer NPs, nonenzymatic POCL systems have been developed and widely applied for *in vivo* CL imaging assays, in which the oxidation of the probes and the generation of high-energy dioxetanedione intermediate excited the fluorescent dyes. Meanwhile, the CL color is adjustable through changing the fluorescent dyes in the polymer NPs. Lee et al. first applied POCL NPs (emitted at 630 nm) to image exogenous H~2~O~2~ in mice\'s leg, achieving a detection sensitivity as low as 250 nM for H~2~O~2~ [@B77]. To reduce the self-absorption of tissue, another all-in-one peroxyoxalate NPs with NIR CL were proposed by Kim\'s group [@B10]. The CL substrate bis\[3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl\] oxalate (CPPO) reacted with H~2~O~2~ and generated the 1,2-dioxetanedione intermediate. Then the encapsulated NIR dye 3,3\'-diethylthiadicarbocyanine iodide (Cy5) was excited by 1,2-dioxetanedione with the maximum emission at 701 nm. In addition to H~2~O~2~, glucose level was also detected using this peroxyoxalate NP-based CL imaging strategy. Recently, Kim et al. improved the peroxyoxalate NPs to enhance the intensity and adjustability of CL in imaging H~2~O~2~ [@B78]. As shown in **Figure [4](#F4){ref-type="fig"}A**, a green-emitting dye of 9,10-distyrylanthracene derivative (BLSA) was synthesized to fabricate the NPs and the CL signals from the BLSA/CPPO aggregates can be enhanced by aggregation-enhanced fluorescence. In particular, when doped with a secondary energy acceptor Nile Red, CL would change from green to red through energy transfer, which realized tunable CL for sensitive imaging of H~2~O~2~ and inflammation.

Through encapsulating therapeutic agents, POCL polymer NPs can not only image small molecules but also treat correlative diseases. For example, a chemiluminescent and antioxidant micelle was designed to detect H~2~O~2~ *in vivo* as well as to encapsulate therapeutic agents for H~2~O~2~-associated inflammatory diseases [@B79]. **Figure [4](#F4){ref-type="fig"}B** showed that the fluorescent dyes and hydroxybenzyl alcohol-incorporated copolyoxalate (HPOX) were encapsulated in the amphiphilic block copolymer pluronic F-127 to constitute the micelle, which was then applied to detect and treat lipopolysaccharide (LPS)-induced inflammation in mouse ankles. The overproduced H~2~O~2~ participated in the POCL reaction and as low as 100 nM H~2~O~2~ can be imaged in the inflamed ankles. Furthermore, the antioxidant micelle can scavenge the overproduced H~2~O~2~ availably and release therapeutic antioxidant hydroxybenzyl alcohol. Therefore, this CL antioxidant micelle showed curative effect to H~2~O~2~-induced inflammation and apoptosis. Moreover, a multifunctional POCL polymer NPs-based probe was synthesized for both CL imaging of H~2~O~2~ and tumor therapy [@B80]. CPPO and aggregation-induced emission photosensitizer of TPE-BT-DC (TBD) were co-encapsulated using F-127 and soybean oil via precipitation. After intravenous administration, the as-synthesized C-TBD NPs could preferentially accumulate in the tumor region because of the enhanced permeability and retention effect. Then, the C-TBD NPs emitted at far-red/NIR region and the strong red emission was observed by the naked eye, realizing tumor tracking. Meanwhile, the TBD in C-TBD NPs would generate ^1^O~2~ efficiently, which could lead to the apoptosis of tumor cells and realize the accurate and noninvasive tumor therapy. Further, β-phenylethylisothiocyanate was used to increase the H~2~O~2~ concentration in both tumor imaging and therapy.

Intragranular CRET or FRET in POCL polymer NPs can adjust CL emission to red shift and therefore improve the ability of light to penetrate tissue. Rao et al. monitored the drug-induced ROS and reactive nitrogen species simultaneously by combining CRET with FRET in the liver of living mice (**Figure [5](#F5){ref-type="fig"}A**) [@B81]. Semiconducting POCL polymer NPs were synthesized with two polymers for real-time monitoring the stress changes of ONOO^-^ and H~2~O~2~ caused by anti-pyretic acetaminophen and anti-tuberculosis agent isoniazid. In the synthesis of this CRET-FRET-polymer NPs (CF-polymer NPs), poly(2,7-(9,9-dioctylfluorene)-alt-4,7-bis(thiophen-2-yl)benzo-2,1,3-thiadiazole) acted as the FRET donor and the CRET acceptor, in which CPPO was the CL substrate for H~2~O~2~ and a cyanine dye was used for the fluorescence-based sensor. Meanwhile, a galactosylated graft copolymer PS-g-PEG-Gal was modified on the CF-polymer NPs, which can target the CF-polymer NPs to the liver accurately. The imaging of hepatotoxicity can be completed within minutes and the LOD for CL imaging of H~2~O~2~ was 5 nM. To monitor H~2~O~2~ concentration*in vivo* with higher sensitivity, the intensity and stability of CL light emission as well as the visualization of imaging have been improved. Pu et al. synthesized another kind of semiconducting POCL polymer NPs for the amplification of CL signals through facilitating electron transfer between molecules (**Figure [5](#F5){ref-type="fig"}B**) [@B82]. The semiconducting POCL polymer NPs was synthesized by coprecipitating bis(2,4,6-trichlorophenyl) oxalate (TCPO) with different polyfluorene-based semiconducting polymers and PEG-*b*-PPG-*b*-PEG. Further, a naphthalocyanine dye was doped into the POCL polymer NPs to generate NIR luminescence via intraparticle CRET between the CL substrate and the luminescence reporter. The results showed that the CL quantum yields were related to the energy difference, and the CL efficiencies of these polymer NPs were irrelevant to their fluorescence quantum yields. Among five polyfluorene-based semiconducting polymers, PFPV-based polymer NPs had the highest fluorescence intensity. Thus, PFPV was chosen as the luminescent reporter. This method achieved sensitive imaging of H~2~O~2~ that was related to peritonitis and neuroinflammation in mice. Recently, poly(phenylenevinylene) (PPV) was observed with continuous afterglow luminescence after removal of light source. So PPV-based semiconducting polymer NPs were synthesized via nano-coprecipitation, which realized the photothermal therapy (PTT) of tumors and monitored the photothermal temperature using afterglow imaging [@B83].

Just like POCL probes for imaging H~2~O~2~, polymer polycaprolactone monoacrylate (PCLA) was also found to be an excellent material in CL imaging for the detection of O~2~^●-^ in mice based on CRET [@B84]. As shown in **Figure [5](#F5){ref-type="fig"}C**, the polymer PCLA-O~2~^●-^ nanoprobe was prepared by nanoprecipitation. Two segments of imidazopyrazinone and conjugated polymers (CPs) were connected through the covalent bond and they acted as the energy donor and acceptor, respectively. Once the O~2~^●-^ was added, a radiationless energy-transfer was occurred from imidazopyrazinone to CPs with the emission of magnified light (λ~max~ = 560 nm). The utilizing of CRET eliminated some inherent shortcomings of CL in optical imaging, such as short emission time and wavelength. The PCLA-O~2~^●-^ nanoprobe exhibited high sensitivity in the detection of O~2~^●-^ at picomole level with prolonged CL time and prominent biocompatibility. In addition, coelenterazine was also found to be a sensitive reporter of intracellular O~2~^●-^, and the function and mass of beta cells were monitored by O~2~^●-^ imaging [@B85].

3.2. Inorganic material-based CL imaging {#Section3.2}
----------------------------------------

Although the POCL reactions have demonstrated highly sensitive and selective response in *in vivo* CL imaging, most reagents used in POCL were hydrophobic. Recently, a hydrophilic POCL silica nanodevice was developed for intracellular imaging of H~2~O~2~ that was generated by oxidase-catalyzed biomarkers and was further applied for high throughput screening of insulin sensitizers [@B86]. In this POCL system (**Figure [6](#F6){ref-type="fig"}A**), CPPO and fluorescent reporter rhodamine B (RhB) were doped into the mesoporous silica NPs. The electrostatically adsorbed oxidases on the surface can not only catalyze the generation of H~2~O~2~ but also protect CPPO from leakage. Glucose in HepG2 cells and other oxidase-catalyzed biomarkers, such as lactic acid, uric acid, and ethanol, were imaged accurately using this POCL silica nanodevice. Besides, by adsorbing glucose oxidase (GOx) onto the surface of silica NPs, insulin sensitizers were successfully identified.

In addition to nonenzymatic POCL systems, based on silicon matrix, dual-functional NPs containing both HRP and Firefly luciferase (FLuc) were synthesized for in situ sequential imaging of ATP and H~2~O~2~ *in vivo* and *in vitro* (**Figure [6](#F6){ref-type="fig"}B**) [@B87]. For the synthesis of HRP-SiO~2~\@FLuc NPs, HRP was the core with the hydrolysis of tetraethyl orthosilicate. The surface of the core was amino-modified by (3-aminopropyl) triethoxysilane, and then Fluc was conjugated to the surface as shell. In the presence of ATP, enzymatic reaction of Fluc-~D~-luciferin was carried out and the CL signals were imaged immediately. Then, HRP-SiO~2~ core was broken at pH 5.5 and H~2~O~2~ was imaged by adding luminol. Two sequential CL signals were continuously recorded and imaged by a CL imaging system. The proposed strategy using HRP-SiO~2~\@FLuc nanoprobes successfully achieved sequential and sensitive detection of ATP and H~2~O~2~ in serum and BALB/c nude mice.

Despite the increasing applications of organic dyes and polymer NPs, there are inherent limitations in CL imaging such as low light intensity. Alternatively, QDs with high quantum yield exhibit good stability against photobleaching. In order to reduce the cytotoxicity of QDs and increase their biocompatibility for *in vivo* imaging, polymer-covered and surface-modified QDs, poly(ethylene glycol)-QDs (PEG-QDs), were fabricated [@B88]. To detect *in vitro* and in *vivo* H~2~O~2~, PEG and luminol derivative L012 were modified on the surface of QDs. CRET occurred in the L012-H~2~O~2~ CL system and the energy transferred to acceptor PEG-QDs, leading to a NIR emission. The detection limit of 0.5 μM exhibited sufficient sensitivity of this hybrid NPs for the detection of abnormal increased H~2~O~2~ level in mice.

3.3. Dioxetane-based CL imaging {#Section3.3}
-------------------------------

Multiple CL substrates containing 1,2-dioxetane unit have been used in *in vivo* CL imaging assays, such as 3-(2′-spiroadamantyl)-4-methoxy-4-(3″-phosphoryloxyphenyl)-1,2-dioxetane (AMPPD) [@B89] and disodium 2-chloro-5-(4-methoxyspiro{1,2-dioxetane-3,2\'-(5\'-chloro)tricyclo \[3.3.1.1^3,7^\]decan}-1-4-yl)-1-phenyl phosphate (CDP-Star) [@B90]. In recent years, more and more novel 1,2-dioxetane-based CL probes have been synthesized [@B91]. For example, Sijbesma\'s group developed a series of novel polymer for the research of mechanoluminescences. In this method, bis(adamantyl)-1,2-dioxetane unit was incorporated in a polymer chain or network to serve as luminescent mechanophore. After the polymeric chain or the network was treated with sonication, dioxetane crosslinkers were fractured and visible bright-blue CL was generated. The mechanically activated CL can transfer to suitable acceptors for color changes. Using 1,2-dioxetane as probe, real-time imaging of CL in chain-scission events can sense deformations, stresses and damage in polymers with high sensitivity [@B92].

Tissue oxygenation is a crucial indicator of tumor microenvironment and hypoxia usually leads to an increase of nitroreductase (NTR) in tumor cells. To real-time monitor NTR *in vivo*, an oxygen-dependent reductive probe, hypoxia chemiluminescent probe **2** (HyCL-**2**), was synthesized using 1,2-dioxetane scaffold for sensitive NTR CL imaging [@B93]. As shown in **Figure [7](#F7){ref-type="fig"}A**, H1299 lung tumors were grown subcutaneously in mice first. Then, tumor oxygenation was adjusted to 21% and 100% oxygen respectively before CL imaging using HyCL-**2**. After injecting a solution of HyCL-**2** and Emerald II enhancer in both mice, higher CL emission was imaged in 21% oxygen, which indicated that HyCL-**2** provided increased signals under low oxygenation condition in tumors. Further, due to the high stability and reduced background, HyCL-**2** showed ∼170-fold increase in CL intensity in comparison with other small molecule reductants. Except for the above Emerald-II enhancer, dioxetane-fluorophore conjugates were also found to be remarkable enhancers for *in vivo* CL imaging of enzyme. Shabat et al. fabricated three turn-on fluorophore-tethered dioxetane CL probes for β-galactosidase imaging (**Figure [7](#F7){ref-type="fig"}B**) [@B94]. The resulting phenolate emitted various colors which conformed the fluorophore ultimately. Under the physiological condition, energy-transfer from excited dye (fluorescein or quinone-cyanine) to peroxy-dioxetane bond amplified the CL signal significantly without an external enhancer. Using CL microscopy,*in vivo* imaging was recorded after subcutaneous and intraperitoneal injection of the synthesized probes. The overexpression of β-galactosidase in HEK293 cells was also imaged sensitively.

Recently, to improve the thermal stability of the probes under physiological conditions, Shabat\'s group synthesized a series of thermostable dioxetane probes with enhanced CL emission in aqueous solution [@B95]. In consideration of the low quantum yield emission of excited state benzoate molecule released from Schaap\'s dioxetane, functionalization at the ortho-position of the phenol was adopted with highly enhanced CL emission. Different electron-withdrawing groups, such as acrylate and acrylonitrile, were installed on phenol donor [@B96]. The light emission intensity of the as-synthesized luminophore showed more than 3 orders of magnitude higher than that of the standard commercially available adamantylidene-dioxetane probe, achieving sensitive imaging of β-galactosidase and ^1^O~2~ in cells [@B97]. Furthermore, through introducing dicyanomethylchromone to an extended π-electron system at the para-position of the phenol as acceptor, a luminophore with NIR emission was obtained with the maximum emission wavelength of 690 nm, which realized the CL imaging of both *in vitro* β-galactosidase and *in vivo* H~2~O~2~ [@B98]. In addition, elongated π-system and electron-withdrawing group were introduced to conventional Schaap\'s adamantylidene-dioxetane to increase the CL emission [@B99]. Then CGKRK peptide was conjugated on the luminophore using a maleimide as linker, which thus increased the aqueous solubility and cell permeability of luminophore under aqueous condition, realizing the first CL microscopy cell-imaging for cathepsin B detection. Besides, other novel luminophores such as CL formaldehyde probes [@B100], turn-on CL prodrug probes [@B101] and afterglow luminescent NPs with aggregation induced emission [@B102] were also synthesized for *in vivo* biosensing and cancer treatment.

4. BL imaging {#Section4}
=============

Biological self-luminescence is a luminescence phenomenon produced by living organisms and the energy comes from enzymatic reactions rather than external light source [@B103]. Through sequencing and cloning, various luciferases were obtained from beetle and submarine luminescent animals for BL imaging [@B104], [@B105]. In *in vivo* BL imaging, luciferase is introduced into mammals or the luciferase gene is integrated into the cell chromosome, which then catalyzes the substrate luciferin to generate BL [@B106]. In BL process, no external light is required, and the efficiency from chemical energy to light energy is almost 100% [@B107]. Because of the high sensitivity, timeliness and good biocompatibility, BL imaging systems have now been widely applied to study tumor growth and metastasis [@B108], cell apoptosis and tracking [@B109], bacterial and virus infection [@B110], protein interactions and transgenes [@B111] in life sciences, medical researches and drug development. In addition, re-engineered luciferases and chemical modification of the substrates further expand the applications of BL imaging [@B112], [@B113]. Furthermore, some novel probes, such as upconversion NPs and QDs have been integrated with the traditional luciferase systems to improve the imaging sensitivity [@B114]-[@B116]. With the advances in imaging technologies, such as modular low-light microscope, BL imaging has become more and more popular [@B117]-[@B119]. In the previous reviews, the traditional luciferase-luciferin BL imaging systems have been systematically summarized [@B120]-[@B126]. Among them, ~D~-luciferin-Fluc, ~D~-luciferin-click beetle luciferase, *Renilla reniformis* luciferase (RLuc)-coelenterazine and *Gaussia princeps* luciferase (GLuc)-coelenterazine pairs have been applied in BL imaging of gene expression, protein interactions, enzyme activities and transplanted cells. In this review, we not only summarize the traditional luciferase-luciferin reporters, but also demonstrate new luciferases and genetic engineering as well as novel BL substrates.

4.1. In situ formation of luciferase for BL imaging {#Section4.1}
---------------------------------------------------

Because of the good biocompatibility and high sensitivity, BL imaging has been applied to study the processes and pathways in neurological disorders, especially the brain-related inflammation and diseases [@B127]. Alzheimer is a neurodegenerative disease, which closely relates to the production and deposition of Aβ peptide [@B128]. Gfap-luciferase was used to monitor the accumulation of Aβ in transgenic mouse models by a rapid, noninvasive and quantitative BL imaging strategy [@B129]. Moreover, the effects of combretastatin-A4P on brain tumor xenografts were tracked in real time using dynamic BL imaging both in 9L rat glioma cells and living mice brain [@B130]. To improve the accuracy, in situ formation of luciferase was introduced to *in vivo* BL imaging, which can greatly reduce the imaging background. For example, the split-Fluc reporter system has been successfully applied to monitor the formation of α-synuclein (αSYN) oligomers through the release of Fluc after interaction between N-terminal (NFluc) and C-terminal (CFluc) part of Fluc, which demonstrated that the inhibitor FK506 can reduce the oligomerization of αSYN [@B131].

Sphingosine-1-phosphate receptor 1 (S1P~1~) is one of the G protein-coupled receptors and is widely distributed in tissues, which plays an important role in both nervous and immune systems. Richard\' group constructed a genetic model in U2OS cells, in which S1P~1~ and β-arrestin2 were linked to CLuc and NLuc, respectively (**Figure [8](#F8){ref-type="fig"}**) [@B132]. The activation of S1P~1~ promoted its interaction with β-arrestin2, leading to the association of inactive luciferase fragments and the production of an active enzyme complex S1P~1~-CLuc/NLuc-β-arrestin2. In the presence of ATP and ~D~-luciferin, the BL images were recorded clearly. After the model was optimized, S1P~1~ activation was used to monitor LPS caused inflammation in brain of mice via real-time BL imaging.

4.2. Luciferase mutants for BL imaging {#Section4.2}
--------------------------------------

The choice of luciferase is crucial in BL imaging. The commonly used luciferases, such as Fluc and GLuc, are often limited in the imaging of deep tissues and cell tracking. Even the emerging NanoLuc is still restricted by the emission of predominantly blue. Thus, the development of novel luciferase genes and mutants has been of great concern over the past decade. Transformed by genetic engineering and functional groups, novel luciferases are increasingly applied in BL systems. Among them, a thermostable red-shifted luciferase PpyRE9H (λ~max~ = 617 nm) was designed to study parasite infections in deep tissue [@B133]. In this work, the gene of PpyRE9H was mutated by 5\'-variant surface glycoprotein and 3′-tubulin untranslated regions, which showed high sensitivity in BL imaging. Moreover, PLG2 luciferase was found to be a reliable substitute to luc2 gene for imaging ATP with enhanced thermal and pH stability combining with beetle luciferin [@B134]. To improve the selectivity of the substrate, Spencer et al. synthesized a series of luciferases with mutated active sites and aminoluciferin substrates (**Figure [9](#F9){ref-type="fig"}A**) [@B135]. It has been found that the strong BL signals can be imaged from the luciferase L342A that was produced by the mutation of leucine 342 using the aminoluciferin CycLuc2-amide, which achieved substrate selectivity as expected.

The cell tracking and intercellular communicates have been systematically studied by BL imaging using a triple imaging system containing FLuc, GLuc and *Vargula hilgendorfii* luciferase [@B136]. At the same time, the oscillation kinetics and cellular mechanisms of cells were also well investigated [@B137], [@B138]. But multicomponent imaging of cells was also limited by the poor substrate selectivity of luciferases. To differentiate cell types, a family of orthogonal luciferase-luciferin pairs were produced through steric modification [@B107]. As shown in **Figure [9](#F9){ref-type="fig"}B**, residues 218, 249-251, and 314-316 were selected to mutagenesis. The mutated luciferase library was then incubated with sterically modified luciferins. Based on the proximity between luciferase and the C7\', C4\' of luciferins, functional mutants were screened out accurately, which was also used to study the orthogonality of other mutants and analogues. Multiple orthogonal pairs with different light emission were screened out and successfully used for BL imaging of different cells, demonstrating that this library screening strategy provided a powerful method for exploring new BL probes. Very recently, Miyawaki et al. synthesized the Akaluc via the iterative screening of candidates with multiple cycles [@B109]. Using AkaLumine as substrate, the BL emission was significantly enhanced and both *in vitro* and*in vivo* imaging of tumorigenic cells were realized. Furthermore, the NIR emission of BL made it penetrated body walls easily, achieving BL imaging of single-cell in deep tissue of moving mice using AkaLumine-Akaluc pairs.

Dual-color imaging was also used to improve the sensitivity of BL imaging [@B139]. Mayu et al. used Emerald Luc and Stable Luciferase Red as reporters to track the subcellular localization and gene expressions simultaneously [@B140]. Dual-color system of red and green was also used for malaria research, which achieved single-cell imaging as well as the measurement of stage-specific drug effects on parasites [@B141]. The intestinal persistence of *lactobacillus plantarum* and *lactococcus lactis* was monitored through combination of CBRluc and CBGluc with dual-color BL imaging strategy [@B142]. Through combining beetle luciferin analogues and different engineered Fluc, Amit et al. developed a series of BL systems emitted from far red to NIR light [@B143].

4.3. In situ formation of luciferin for BL imaging {#Section4.3}
--------------------------------------------------

In situ release of luciferin was as effective as target-triggered luciferase formation. So far, a series of luciferin-based conjugates have been reported for *in vivo* BL imaging. A turn-on BL probe containing nitro group was designed for visualization of endogenous NTR in living cells and mice with high selectivity and selectivity (**Figure [10](#F10){ref-type="fig"}A**) [@B144]. In this study, ~D~-luciferin-Fluc pair with different caged groups and linkers was used. After mixing BL probe with NTR and cofactor NADH, the selective reduction occurred and the nitro group in the probe transformed into amino group. Then cleavage reaction led to the release of free firefly luciferin to activate the catalytic reaction with luciferase and subsequently produced a photon. Even 0.001 μg/mL of NTR can be explicitly observed using this probe.

Luciferin-based BL imaging probes were also used to detect*in vivo* metal ions. For example, iron-caged luciferin-1 (ICL-1), an endoperoxide-luciferin conjugate, was synthesized for longitudinal monitoring of labile iron pools in living mice [@B145]. The presence of Fe^2+^ caused the cleavage of conjugate and the release of ~D~-aminoluciferin, which generated an increased BL signal that was correlated with the amount of Fe^2+^. Very recently, the accumulation of Co^2+^ was also imaged via the split of luciferin-based conjugate [@B146]. The Co^2+^ BL probe 1 (CBP-1) was synthesized using the N~3~O ligand and a C-O benzyl ether bond, in which the tetradentate ligand N~3~O was the trigger for Co^2+^. As shown in **Figure [10](#F10){ref-type="fig"}B**, only in the presence of Co^2+^, ~D~-luciferin substrate was released due to the cleavage of Co^2+^-mediated C-O bond in CBP-1, resulting in an increased BL intensity. Using the CBP-1, the accumulation and fluctuation of Co^2+^, as well as ATP and luciferase, were sensitively monitored real-time in a mouse model.

Besides metal ions, CO in living cells and mice was also imaged using BL based on the Tsuji-Trost reaction of allyl-luciferin probe [@B147]. Non-luminous luciferin-based conjugate of allyl-luciferin was synthesized and used as a novel BL probe. After injecting allyl-luciferin and PdCl~2~-containing liposomes intraperitoneally and intratumorally, \[Ru(CO)~3~Cl-(glycinate)\] was then injected to produce exogenous CO. Subsequently, PdCl~2~ was reduced to Pd^0^ by CO and Pd^0^-mediated Tsuji-Trost reaction led to the yield of ~D~-luciferin, realizing the real-time BL imaging of CO. This turn-on probe demonstrated good sensitivity and selectivity to both exogenous and endogenous CO. Moreover, a silent BL probe acrylic ester luciferin was synthesized for Cys detection both *in vitro* and *in vivo* (**Figure [10](#F10){ref-type="fig"}C**) [@B148]. The BL probe was synthesized through caging hydroxyl group of ~D~-luciferin motif by acrylic ester. In the presence of Cys, a conjugate addition of Cys to acrylate occurred, leading to the in situ release of ~D~-luciferin for BL imaging. This BL probe could selectively detect Cys with a LOD of 88 nM *in vitro*, and Cys in living mice was also sensitively analyzed.

In addition to luciferin-based conjugates, in situ formation of luciferin via a pair of complementary precursors was also applied in BL imaging [@B149]. Based on the formation of luciferin by two complementary precursors, Genevieve et al. presented an AND-type logic gate to detect H~2~O~2~ and caspase 8 activity simultaneously [@B150]. As shown in **Figure [10](#F10){ref-type="fig"}D**, the probes of peroxy caged luciferin-2 (PCL-2) and z-Ile-Glu-ThrAsp-~D~-Cys were synthesized with luciferin precursors respectively. After suffering from inflammation in mice (injection of LPS), the resulting H~2~O~2~ induced PCL-2 to produce 6-hydroxy-2-cyanobenzothiazole (HCBT) and the generated caspase 8 led to the release of ~D~-cysteine via biochemical cleavage. The firefly luciferin was then in situ formed through a facile cyclization reaction between HCBT and ~D~-cysteine, and the BL imaging was performed in the presence of Fluc for simultaneous detection of H~2~O~2~ and the activity of caspase 8. This method provided a powerful tool for concurrent monitoring and research of inflammation. In addition, caspase 3 was also sensitively imaged by N- and C-terminal fusion of the luciferin fragments [@B9], [@B151].

4.4. Luciferin analogs for BL imaging {#Section4.4}
-------------------------------------

~D~-luciferin is one of the most commonly used enzyme substrates to penetrate into cells, tissues and even whole organisms for imaging. Thus, simple and efficient synthesis of luciferin is of great importance to BL imaging. David et al. reported a rapid method to synthesize ~D~-luciferin and a series of electronically modified nitrogenous analogues [@B152]. In the synthesis process, dithiazolium reagent was used to generate the heteroaromatic scaffolds in a divergent fashion. Two of the benzimidazole analogues with robust emission were found and applied in BL imaging in live cells. This synthesis method expanded the types of luciferin as well as the ability to rapidly access new luciferin substrates.

To satisfy the need of multicolor imaging, better biocompatibility and deep tissue penetration, the chemical modification of luciferin and the corresponding luciferin analogs came into being which emitted from the far-red to NIR ranges. The structures of ~D~-luciferin as well as some ~D~-luciferin-based analogs have been reported [@B153]. Retooling BL technology allowed the alteration of oxhydryl and sulfur atom of ~D~-luciferin, therefore aminoluciferin, alkylaminoluciferin and other analogs were designed and applied to deep BL imaging *in vivo* [@B154], [@B155]. Further, a series of N-cyclo-alkylaminoluciferins and novel N-cyclobutylaminoluciferin were reported based on aminoluciferins [@B156].

Altering the 6′-position of ~D~-luciferin via alkylation or acylation is an effective method to prepare luciferin analogs. To improve the sensitivity of *in vivo* BL imaging, Melanie et al. synthesized a new luciferin analog cyclic alkylaminoluciferin (CycLuc1) (**Figure [11](#F11){ref-type="fig"}A**) [@B157]. Through combing with the existing Fluc, CycLuc1 showed higher luminescence intensity, better light persistence and less dosage than ~D~-luciferin, which was used to sensitively image 4T1 breast cancer cells and living mice. Although CycLuc1 as a novel luciferin has higher sensitivity than ~D~-luciferin, its emission intensity (λ~max~ = 604 nm) in deep tissues is still weak or even unobservable. To achieve stronger penetration and lower tissue absorption, Takahiro et al. demonstrated a new luciferin analogue AkaLumine-HCl (Aka-HCl), which had the NIR emission (λ~max~ = 677 nm) and a significantly improved sensitivity in deep tissues (**Figure [11](#F11){ref-type="fig"}B**) [@B158]. The penetration efficiency of Aka-HCl was 5- and 8.3-fold higher than ~D~-luciferin and 3.7- and 6.7-fold higher than CycLuc1 in 4- or 8-mm-thick tissue sections, respectively, presenting great potential in the detection of preclinical cancers. Similarly, based on the previous BL luciferin derivative 5′-fluoro and other small substituents [@B159], Rachel et al. successfully synthesized the ~D~-luciferin-based 5′-alkyne derivative using C-H activation methodology [@B160]. The emission of alkynyl luciferin was comparatively red-shifted and its spectrum was similar to aminoluciferin. Meanwhile, this alkynyl luciferin was found to have good cell permeability after incubation with HEK293 cells.

Another challenge of luciferin in BL imaging is the durability of light emission. Only a long-time and real-time imaging *in vivo* or intracellular can reveal the intricate molecular dynamics. For example, the overexpression of fatty acid amide hydrolase (FAAH) is closely related to the nervous system diseases. However, current BL imaging of FAAH can only last 5 h [@B161]. To better explain the nosogenesis of FAAH, Yue et al. designed a ~D~-luciferin-based BL probe (~D~-Cys-Lys-CBT)~2~ for intracellular BL imaging [@B162]. As shown in **Figure [11](#F11){ref-type="fig"}C**, after (~D~-Cys-Lys-CBT)~2~ entered the cells via endocytosis, intracellular reduction reaction was triggered by GSH to form cyclic ~D~-luciferin NPs. Cycloaddition promoted the formation of (~D~-Cys-Lys-CBT)~2~-dimer, and (~D~-Cys-Lys-CBT)~2~ NPs were finally formed through the self-assembly of dimers. Before hydrolysis, (~D~-Cys-Lys-CBT)~2~ NPs lurked steadily inside the cells until the emergence of FAAH. FAAH-induced hydrolysis caused the slow release of ~D~-luciferin or its derivatives, which ensured the persistance of BL as well as the long-time tracking of FAAH *in vivo*. It was found that the BL intensity in tumors of mice injected with (~D~-Cys-Lys-CBT)~2~ reached its peak at 24 h and sustained an imageable signal for at least 2.5 days, which was markedly longer than aminoluciferin methyl amide, Lys-amino-~D~-luciferin and amino-~D~-luciferin.

4.5 BRET imaging {#Section4.5}
----------------

Through introduction of acceptor chromophore to BL system, the luminescence generated from luciferase would be transferred to the acceptor chromophore through BRET. In this way, the luminous intensity and the maximum emission of luciferase changed, which displayed significant effect on the sensitivity of BL imaging [@B163]. The signal of BRET is a ratio rather than an absolute quantity, so it could eliminate the data variables that result from cell numbers, cell types, and other experimental variables. Because of the red-shifts of maximum emission, BRET has been increasingly applied to investigate protein interactions and intracellular molecular dynamics [@B164]. For example, Xiong et al. synthesized a self-luminescing BRET-FRET polymer nanoprobe with strong NIR emission for lymph-node mapping and tumor imaging to avoid the short-wavelength autofluorescence *in vivo* [@B165]. Through combining BRET and improved light intensity, Jun et al. reported a fluorescent protein CyOFP1 through engineering the orange-red fluorescent proteins [@B166]. The red-emitting Antares (the fusion of CyOFP1 and NanoLuc) was synthesized using NanoLuc as the donor and CyOFP1 as the acceptor to facilitate the BRET. In comparison with Fluc and other BL proteins, this BL reporter generated greatly brighter signals in deep tissues. Very recently, Yeh et al. successfully synthesized and screened out the analogues of coelenterazine, diphenylterazine (DTZ) and selenoterazine (STZ) (**Figure [12](#F12){ref-type="fig"}**) [@B167]. One mutant of NanoLuc NanoLuc-D19S/D85N/C164H, designated as \'teLuc\', was found to enhance the emission of DTZ with 5.7-fold. The NanoLuc in Antares was replaced with teLuc, and the BRET-based Antares2 reporter was formed. The Antares2-DTZ pairs showed obvious red-shifted emission in comparison with Antares and FLuc-~D~-luciferin, which also demonstrated excellent tissue penetration efficiency in living mice imaging.

In addition to imaging, BRET has also been applied in PDT. Yuan et al. used cationic oligo(p-phenylene vinylene) (OPV) to absorb the CL of luminol and then produce ROS through BRET to kill the adjacent cancer cells and pathogenic microbes*in vivo* [@B168]. Unlike the other PDT strategies, this molecule-induced system used OPV as the photosensitizer, which didn\'t require an external light source.

5. Conclusions and perspectives {#Section5}
===============================

CL and BL imaging have attracted great interest because of their high SNR, wide linear dynamic range and real-time performance. In the field of chemistry and biology, both of them and their derived methods provide powerful tools for*in vitro* and*in vivo* detection of a wide range of analytes. With the emergence of new luminescent materials and systems, as well as the combination with other technologies such as ELISA and molecularly imprinted polymer, the sensitivity and selectivity of CL and BL imaging methods have been significantly improved.

However, there are still some challenges in CL and BL imaging. Firstly, most CL systems are quick and the light emission is completed within seconds so that the data acquisition and imaging is relatively difficult. To overcome this defect, slow CL reactions, such as POCL systems have been reported [@B36]. It is necessary to explore new luminescent agents for reducing the delay between reaction and signal acquisition. Recently, persistent luminescence with long time emission has become a new optical imaging modality, which can avoid autofluorescence and background. So far, more and more persistent luminescence nanoprobes have been explored for bioimaging and therapeutic applications [@B169], [@B170]. Another challenge is the high requirement of instruments. CCD cameras are often limited in microarrays, microplates and high throughput reactions to capture the light signal. Therefore, the development of camera equipment with high resolution, high sensitivity and anti-interference ability is necessary in further applications of CL and BL imaging. In addition, for *in vivo* applications, the absorption of tissues, weak light intensity and multicomponent analysis put forward higher requirements for CL and BL imaging technologies. It is confident that CL and BL imaging will become powerful techniques in the fields of biochemical analysis, clinical diagnosis and treatment of diseases, environmental monitoring, and so on.
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![**CL imaging of cancer cells using multifunctional nanoprobes. (A)** Glycan expression-based CL imaging of HCCC-9810 cells using AuNP probes. Reprinted with permission from [@B28], Copyright 2012, American Chemical Society. **(B)** Dual-aptamer recognition-based CL imaging of Ramos cells using bio-bar-code AuNP probes. Reprinted with permission from [@B35], Copyright 2013, Royal Society of Chemistry. **(C)** Folic acid and HRP-bifunctionalized semiconducting polymer dots for both CL imaging and PDT of tumor cells. Reprinted with permission from [@B44], Copyright 2014, American Chemical Society.](thnov09p4047g001){#F1}

![**Tool enzyme-based isothermal amplification for CL imaging of nucleic acids. (A)** Automated on-chip CL imaging platform based on RPA for simultaneous detection of viruses and bacteria. Reprinted with permission from [@B52], Copyright 2016, American Chemical Society. **(B)** CL imaging for simultaneous amplified detection of three microRNAs via programmable strand displacement-based magnetic separation. Reprinted with permission from [@B57], Copyright 2017, Elsevier B.V.](thnov09p4047g002){#F2}

![The structure of 3D-printed unibody immunoarray for detection of PSA and PF-4. Reprinted with permission from [@B62], Copyright 2017, Royal Society of Chemistry.](thnov09p4047g003){#F3}

![**Polymer NPs-based CL imaging of*in vivo* H~2~O~2~. (A)** BLSA/CPPO NPs with aggregation-enhanced fluorescence for CL imaging of H~2~O~2~. Reprinted with permission from [@B78], Copyright 2012, American Chemical Society. **(B)** Synthesis and application of HPOX micelles in H~2~O~2~ imaging. Reprinted with permission from [@B79], Copyright 2012, Wiley-VCH.](thnov09p4047g004){#F4}

![**POCL polymer NPs-based CRET systems for *in vivo* H~2~O~2~ imaging. (A)** Molecular components of CF-polymer NPs and the mechanism of ONOO^-^/^-^OCl and H~2~O~2~ detection by CF-polymer NPs. Reprinted with permission from [@B81], Copyright 2014, Nature Publishing Group. **(B)** Mechanism of the CRET in semiconducting POCL polymer NPs and the comparison between PFPV-based semiconducting POCL polymer NPs and other four semiconducting-based POCL polymer NPs, as well as *in vivo* CL imaging of endogenous H~2~O~2~ in the mouse model of neuroinflammation. Reprinted with permission from [@B82], Copyright 2016, American Chemical Society. **(C)** O~2~^●-^ sensing and the structure of polymer PCLA-O~2~^●-^, as well as the *in vivo* CL imaging of endogenous O~2~^●-^. Reprinted with permission from [@B84], Copyright 2016, American Chemical Society.](thnov09p4047g005){#F5}

![**Silica NPs-based CL assays for*in vivo* H~2~O~2~ imaging. (A)** Fabrication of POCL silica nanodevice for H~2~O~2~ imaging which was generated by different oxidase-catalyzed biomarkers. Reprinted with permission from [@B86], Copyright 2017, Wiley-VCH. **(B)** Synthesis of the HRP-SiO~2~\@FLuc NPs for in situ sequential imaging of endogenous and exogenous H~2~O~2~. Reprinted with permission from [@B87], Copyright 2016, Wiley-VCH.](thnov09p4047g006){#F6}

![**1,2-dioxetane based CL probes for CL imaging. (A)** *In vivo* imaging of H1299 lung tumor xenografts using HyCL-**2** under different oxygen concentrations. Reprinted with permission from [@B93], Copyright 2016, American Chemical Society. **(B)** CL mechanism of dioxetane-fluorophore conjugates. Reprinted with permission from [@B94], Copyright 2016, American Chemical Society.](thnov09p4047g007){#F7}

![In situ formation of luciferase and the mating scheme of S1P~1~ luciferase signaling mice. Reprinted with permission from [@B132], Copyright 2017, Nature Publishing Group.](thnov09p4047g008){#F8}

![**BL imaging with luciferase mutants. (A)** Crystal structure of luciferase with different mutations, the structure of aminoluciferin analogues, and the performance of mutant luciferase with different luciferins in the brains of live mice. Reprinted with permission from [@B135], Copyright 2016, Wiley-VCH. **(B)** Amino acids targeted for mutagenesis and library screening strategy. Reprinted with permission from [@B107], Copyright 2017, American Chemical Society.](thnov09p4047g009){#F9}

![**Luciferin-based conjugates as BL imaging probes. (A)** *In vivo* release of firefly luciferin for endogenous NTR imaging. Reprinted with permission from [@B144], Copyright 2016, American Chemical Society. **(B)** Synthesis of CBP-1 and *in vivo* imaging of Co^2+^. Reprinted with permission from [@B146], Copyright 2018, American Chemical Society. **(C)** Synthesis of acrylic ester luciferin and *in vivo* imaging of Cys. Reprinted with permission from [@B148], Copyright 2018, American Chemical Society. **(D)** Synchronous imaging of H~2~O~2~ and caspase 8 through in situ formation of luciferin. Reprinted with permission from [@B150], Copyright 2013, American Chemical Society.](thnov09p4047g010){#F10}

![**Luciferin analogs for BL imaging. (A)** Structures and imaging sensitivity of CycLuc1 compared to ~D~-luciferin. Reprinted with permission from [@B157], Copyright 2014, Nature Publishing Group. **(B)** Structures, BL emission spectra and tissue penetration efficiency of AkaLumine-HCl, CycLuc1 and~D~-luciferin. n = 3, \*P \< 0.05 (*t*-test). Reprinted with permission from [@B158], Copyright 2016, Nature Publishing Group. **(C)** Long-term BL imaging of FAAH using (~D~-Cys-Lys-CBT)~2~. Reprinted with permission from [@B162], Copyright 2016, American Chemical Society.](thnov09p4047g011){#F11}

![Chemical structures and BL emission of the synthetic luciferins (DTZ and STZ) as well as their corresponding BL imaging in HEK 293T cells and live mice in the presence of various re-engineered luciferases. Reprinted with permission from [@B167], Copyright 2017, Nature Publishing Group.](thnov09p4047g012){#F12}
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